|
English
|
正體中文
|
简体中文
|
2817768
|
|
???header.visitor??? :
27877083
???header.onlineuser??? :
474
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"thaci d"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2018-09-10T15:28:29Z |
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trials
|
Papp, K.A.;Menter, M.A.;Abe, M.;Elewski, B.;Feldman, S.R.;Gottlieb, A.B.;Langley, R.;Luger, T.;Thaci, D.;Buonanno, M.;Gupta, P.;Proulx, J.;Lan, S.;Wolk, R.; TSEN-FANG TSAI |
國立臺灣大學 |
2016 |
Secukinumab delivers greater improvement in health-related quality of life compared to ustekinumab in subjects with moderate to severe plaque psoriasis: 16-week data from the CLEAR study
|
Rubel, D.; Thaci, D.; Blauvelt, A.; Reich, K.; Tsai, T. F.; Vanaclocha, F.; Kingo, K.; Ziv, M.; Pinter, A.; Hugot, S.; You, R.; Augustin, M.; Milutinovic, M.; 蔡呈芳 |
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
|